Tenascin-C differentiates obstructive from non-obstructive coronary artery disease in non-ST-elevation acute coronary syndrome.
BACKGROUND Differentiating obstructive from non-obstructive coronary artery disease (CAD) at the time of acute coronary syndrome (ACS) diagnosis remains challenging, and there is a need for biomarkers that can provide clearer discrimination. AIM This study aims to assess Tenascin-C's diagnostic utility in predicting...